2. News & RNS
3. Finance News
4. Oddo BHF flags European pharma's attractive growth profile, prefers Novo Nordisk, AstraZeneca

Oddo BHF flags European pharma's attractive growth profile, prefers Novo Nordisk, AstraZeneca

Thu, 29th Sep 2022 11:44

Related Shares

Astrazeneca (AZN)

12,356.00 (28.00 / 0.23%%)

12,390.00 - 12,394.00

Sanofi (SAN.PA)

89.94 (0.08 / 0.089%%)

93.35 - 93.36

Glaxosmithkline (GSK)

1,529.50 (3.50 / 0.23%%)

1,531.50 - 1,532.00

27 Jun 2024 13:00

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

FRANKFURT, June 27 (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca a...

26 Jun 2024 08:40

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar...

25 Jun 2024 09:05

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso.

25 Jun 2024 07:48

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm.

25 Jun 2024 07:17

AstraZeneca posts mixed results from recent Imfinzi trials

(Sharecast News) - AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug 'Imfinzi', or durvalumab, on...